Home R&D Page 15

R&D

Delamanid, a novel drug for multidrug-resistant tuberculosis

Propandiol in infantile haemangioma

New vaccine candidates against malaria enter clinical development

Phase I/II trial on tkm-plk1 in patients with hepatocellular carcinoma

Monoclonal antibody in childhood brain tumor

Helsinky, half a century later

Progress but many remaining challenges

Research

From life’s origins towards artificial life

Mitochondrial-DNA related diseases and genetic manipulation

Dolutegravir, an integrase inibitor, to prevent HIV spread in patients

Antiviral treatment for chronic hepatitis C in adults

1...141516Page 15 of 16
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151